Inside the Eye-Drug Breakthrough That Sent Kodiak Sciences Up 183% Inside the Eye-Drug Breakthrough That Sent Kodiak Sciences Up 183% · Barrons.com · Dreamstime Mackenzie Tatananni September 28, 2026 4 min read KOD -1.22% REGN +13.33% ^RUT -1.66% OTLK -5.15% Kodiak Sciences plans to file for regulatory approval of one drug candidate, Zenkuda, following its success in a trial for wet age-related macular degeneration. Continue Reading Terms and Privacy Policy Your Privacy Choices More Info
